Positive results for ATX-MS-1467 trial in relapsing MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Positive results for ATX-MS-1467 trial in relapsing MS

Postby MSUK » Tue Sep 03, 2013 12:57 am

Apitope announced completion with positive results of its second Phase I clinical trial of ATX-MS-1467. Examination of the MRI results (new Gd and total Gd enhancing lesions) demonstrated a significant decrease in the number of contrast-enhancing brain lesions (CEL) in patients with relapsing multiple sclerosis treated by intradermal injection of ATX-MS-1467. The same effect was not seen in the subcutaneously dosed group. These encouraging results will now need confirmation in appropriate Phase II trials....... Read More - http://www.ms-uk.org/index.cfm/ATXMS1467
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2121
Joined: Wed Oct 14, 2009 3:00 pm

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service